801 N. 30th Street, Suite 6718 — Omaha, Nebraska

801 N. 30th Street, Suite 6718 is a clinical research site located in Omaha, Nebraska, United States 68131.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

801 N. 30th Street, Suite 6718 has participated in 1 clinical trials.

Therapeutic areas: Osteoporosis, Postmenopausal.

Sponsors: Tarsa Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 801 N. 30th Street, Suite 6718?

801 N. 30th Street, Suite 6718 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 801 N. 30th Street, Suite 6718 conducted?

801 N. 30th Street, Suite 6718 has 1 clinical trials on record. Their work covers Osteoporosis, Postmenopausal.

Is 801 N. 30th Street, Suite 6718 accredited by Crixeo Health?

801 N. 30th Street, Suite 6718 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 801 N. 30th Street, Suite 6718?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.